NCT01586624 2021-10-07A Phase I Trial of Vandetanib (AZD6474) and Selumetinib (AZD6244) for Solid Tumours Including Non Small Cell Lung Cancer (VanSel-1)Cancer Research UKPhase 1 Completed61 enrolled 23 charts
NCT00613626 2020-02-11Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung CancerHoosier Cancer Research NetworkPhase 2 Completed74 enrolled 19 charts
NCT00459121 2019-03-26Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by SurgeryBarbara Ann Karmanos Cancer InstitutePhase 2 Terminated2 enrolled 4 charts
NCT00687297 2018-05-30Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung CancerPrECOG, LLC.Phase 2 Completed162 enrolled 9 charts
NCT00364351 2018-01-25Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior ChemotherapySanofiPhase 3 Completed1,574 enrolled 13 charts
NCT00597116 2016-10-10An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant MesotheliomaSanofiPhase 2 Terminated25 enrolled 8 charts
NCT00777179 2016-10-10Phase II of Zactima Maintenance for Locally Advanced or Metastatic Non-small-cell Lung Carcinoma (NSCLC) Following Platinum-doublet ChemotherapySanofiPhase 2 Completed117 enrolled 15 charts
NCT00404924 2016-09-30ZD6474 (ZACTIMAâ„¢) Phase III Study in EGFR FailuresSanofiPhase 3 Completed1,140 enrolled 12 charts
NCT00290537 2016-05-19Phase II Study of ZD6474 in Advanced NSCLCM.D. Anderson Cancer CenterPhase 2 Terminated4 enrolled 3 charts
NCT00402896 2016-03-09Malignant Pleural Effusion With ZD6474M.D. Anderson Cancer CenterPhase 2 Terminated28 enrolled 5 charts
NCT00410189 2015-03-23BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLCM.D. Anderson Cancer CenterPhase 2 Completed54 enrolled 8 charts